Glycine Receptor Activity in β Cells Is Downregulated in Type 2 Diabetes and After High Glucose Culture
RNA-seq (gene expression) · human · 199 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 199 samples: 199 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Molecular correlates of glycine receptor activity in human β cellsMolecular metabolism · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE280267_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1177489 and SRA study SRP540698. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 199 sample titles: 199 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8593424 A3-Nov-2022-Plate2-PEM_S97
- GSM8593425 B3-Nov-2022-Plate2-PEM_S102
- GSM8593426 C3-Nov-2022-Plate2-PEM_S107
- GSM8593427 D3-Nov-2022-Plate2-PEM_S112
- GSM8593428 E3-Nov-2022-Plate2-PEM_S117
- GSM8593429 F3-Nov-2022-Plate2-PEM_S122
- GSM8593430 G3-Nov-2022-Plate2-PEM_S127
- GSM8593431 H3-Nov-2022-Plate2-PEM_S132
- GSM8593432 A4-April-2023-Plate4-PEM_S276
- GSM8593433 A5-April-2023-Plate4-PEM_S277
- GSM8593434 A6-April-2023-Plate4-PEM_S278
- GSM8593435 A7-April-2023-Plate4-PEM_S279
- GSM8593436 B4-April-2023-Plate4-PEM_S286
- GSM8593437 B5-April-2023-Plate4-PEM_S287
- GSM8593438 B6-April-2023-Plate4-PEM_S288
- GSM8593439 B7-April-2023-Plate4-PEM_S289
- GSM8593440 C4-April-2023-Plate4-PEM_S296
- GSM8593441 C5-April-2023-Plate4-PEM_S297
- GSM8593442 C6-April-2023-Plate4-PEM_S298
- GSM8593443 C7-April-2023-Plate4-PEM_S299
- GSM8593444 D4-April-2023-Plate4-PEM_S306
- GSM8593445 D5-April-2023-Plate4-PEM_S307
- GSM8593446 D6-April-2023-Plate4-PEM_S308
- GSM8593447 D7-April-2023-Plate4-PEM_S309
- GSM8593448 E4-April-2023-Plate4-PEM_S316
- GSM8593449 E5-April-2023-Plate4-PEM_S317
- GSM8593450 E6-April-2023-Plate4-PEM_S318
- GSM8593451 E7-April-2023-Plate4-PEM_S319
- GSM8593452 F4-April-2023-Plate4-PEM_S326
- GSM8593453 F5-April-2023-Plate4-PEM_S327
- GSM8593454 F6-April-2023-Plate4-PEM_S328
- GSM8593455 F7-April-2023-Plate4-PEM_S329
- GSM8593456 G4-April-2023-Plate4-PEM_S336
- GSM8593457 G5-April-2023-Plate4-PEM_S337
- GSM8593458 G6-April-2023-Plate4-PEM_S338
- GSM8593459 G7-April-2023-Plate4-PEM_S339
- GSM8593460 H4-April-2023-Plate4-PEM_S346
- GSM8593461 H5-April-2023-Plate4-PEM_S347
- GSM8593462 H6-April-2023-Plate4-PEM_S348
- GSM8593463 H7-April-2023-Plate4-PEM_S349
+ 159 more — browse all 199 samples with per-sample file links →
- GSE280810 Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and anti-tumoral activity upon IL-10 or TGFβ stimulation 30 samples shares receptor, activity, type
- GSE279480 Longitudinally stable T cell and innate immune activity distinguish healthy adult immunotypes I 1021 samples shares activity, type
- GSE314304 IL-11 receptor is a novel target for drug development with pharmacological activity in fibro-inflammatory disease 96 samples shares receptor, activity
- GSE278330 Systemic IL-23 blockade downregulates IL-23 receptor-expressing Type 17 T-cell subsets and upregulates regulatory gene expression in myeloid cells in human psoriasis skin 63 samples shares receptor, type
- GSE284664 RESET: A reversible TCR-coupled antigen receptor with superior targeting sensitivity and pharmacologically controlled anti-tumor activity 62 samples shares receptor, activity
- GSE316337 Multi-omics profiling reveals microbiota, metabolite, lipid, and immunological heterogeneity underlying distinct pathophysiological mechanisms of age-related endotypes in type 1 diabetes 54 samples shares diabetes, type
- GSE309967 Immunometabolic Endotypes Define Distinct Clinical Trajectories in Type 2 Diabetes 48 samples shares diabetes, type
- GSE309941 Immunometabolic Endotypes Define Distinct Clinical Trajectories in Type 2 Diabetes [bulk RNA-seq] 42 samples shares diabetes, type
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.